TCPI (Technical Chemicals and Products) cleared to sell home urine test in US:
This article was originally published in Clinica
Executive Summary
Technical Chemicals & Products (TCPI), which was given FDA approval to market a Protein-in-Urine home screening test, will begin sales of the product in late 1998 or early 1999. The home test, which will sell for $9.99 for three test strips and indicates for possible kidney, bladder, liver or diabetic disorders, is the third test that TCPI has added to its range in the past 12 months. The Pompano Beach, Florida-based company says that the launches are a conscious move to commercialise its product portfolio.
You may also be interested in...
EU: Good News For IVDs And For Future Transparency Of Medtech Compliance
The IVD industry has long been awaiting a further extension of the deadlines for compliance with the IVD Regulation and for the launch date of the Eudamed database to be brought forward.
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.